CN114555060A - 具有水溶性黏膜黏附性聚合物的离子交换组合物 - Google Patents

具有水溶性黏膜黏附性聚合物的离子交换组合物 Download PDF

Info

Publication number
CN114555060A
CN114555060A CN202080071199.0A CN202080071199A CN114555060A CN 114555060 A CN114555060 A CN 114555060A CN 202080071199 A CN202080071199 A CN 202080071199A CN 114555060 A CN114555060 A CN 114555060A
Authority
CN
China
Prior art keywords
water
tablet
oral tablet
soluble anionic
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080071199.0A
Other languages
English (en)
Chinese (zh)
Inventor
肯特·阿尔宾·涅尔森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fertin Pharma AS
Original Assignee
Fertin Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fertin Pharma AS filed Critical Fertin Pharma AS
Publication of CN114555060A publication Critical patent/CN114555060A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202080071199.0A 2019-10-11 2020-10-09 具有水溶性黏膜黏附性聚合物的离子交换组合物 Pending CN114555060A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/599,991 US20210106516A1 (en) 2019-10-11 2019-10-11 Ion-Exchange Composition With Water-Soluble Mucoadhesive Polymers
US16/599,991 2019-10-11
PCT/DK2020/050280 WO2021069044A1 (en) 2019-10-11 2020-10-09 An ion-exchange composition with water-soluble mucoadhesive polymers

Publications (1)

Publication Number Publication Date
CN114555060A true CN114555060A (zh) 2022-05-27

Family

ID=73198078

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080071199.0A Pending CN114555060A (zh) 2019-10-11 2020-10-09 具有水溶性黏膜黏附性聚合物的离子交换组合物

Country Status (6)

Country Link
US (1) US20210106516A1 (https=)
EP (1) EP4041191A1 (https=)
JP (1) JP7763166B2 (https=)
CN (1) CN114555060A (https=)
CA (1) CA3153792A1 (https=)
WO (1) WO2021069044A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022234522A1 (en) * 2021-05-06 2022-11-10 Nicoventures Trading Limited Oral compositions and related methods for reducing throat irritation
CA3233375A1 (en) 2021-09-30 2023-04-06 Michael Zawadzki Oral product with a basic amine and an ion pairing agent
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product
JP2026509969A (ja) * 2023-01-27 2026-03-26 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 活性成分の経口送達のためのシステム
WO2024156323A1 (en) * 2023-01-27 2024-08-02 Fertin Pharma A/S An adhesive oral disc for sustained release of cannabinoids
DK182278B1 (en) * 2023-07-07 2026-02-04 Fertin Pharma As Dissolvable orally adhering tablet
DK182273B1 (en) * 2023-07-07 2026-01-30 Fertin Pharma As Dissolvable orally adhering nicotine tablet
WO2025011727A1 (en) * 2023-07-07 2025-01-16 Fertin Pharma A/S Dissolvable orally adhering nicotine tablet

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997042941A2 (en) * 1996-05-13 1997-11-20 Novartis Consumer Health S.A. Buccal delivery system
WO2000025757A1 (en) * 1998-10-29 2000-05-11 Merck & Co., Inc. Sustained release delivery of highly water-soluble compounds
US20050181050A1 (en) * 2004-01-28 2005-08-18 Collegium Pharmaceutical, Inc. Dosage forms using drug-loaded ion exchange resins
EP2233134A1 (en) * 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
WO2012083947A1 (en) * 2010-12-21 2012-06-28 Fertin Pharma A/S Chewing gum composition comprising cross-linked polyacrylic acid
CN104271137A (zh) * 2012-03-26 2015-01-07 阿特法克特里公司 包含封装在水不溶性袋中的粉末的尼古丁口服递送产品,其中所述粉末包括尼古丁和口香糖组合物
US20170172995A1 (en) * 2015-09-08 2017-06-22 Venkateswara Rao Repaka Pharmaceutical compositions of Nicotine and process for preparation thereof
WO2018113916A1 (en) * 2016-12-20 2018-06-28 Fertin Pharma A/S A mucoadhesive oromucosal formulation comprising a nicotine complex
CN109952092A (zh) * 2016-11-18 2019-06-28 费尔廷制药公司 包含独立的黏合剂和赤藓糖醇的片剂
CN109963553A (zh) * 2016-11-18 2019-07-02 费尔廷制药公司 经口递送载剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901248A (en) 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
WO2005053691A2 (en) * 2003-12-02 2005-06-16 Fertin Pharma A/S Nicotine delivery product and method for producing it
WO2005055945A2 (en) * 2003-12-08 2005-06-23 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
CA2758618C (en) * 2009-04-24 2017-03-28 Omya Development Ag Particulate material for controlled release of active ingredients
US10632076B2 (en) * 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
US11058633B2 (en) * 2018-05-17 2021-07-13 Fertin Pharma A/S Disintegrating oral tablet suitable for active pharmaceutical ingredients

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997042941A2 (en) * 1996-05-13 1997-11-20 Novartis Consumer Health S.A. Buccal delivery system
WO2000025757A1 (en) * 1998-10-29 2000-05-11 Merck & Co., Inc. Sustained release delivery of highly water-soluble compounds
US20050181050A1 (en) * 2004-01-28 2005-08-18 Collegium Pharmaceutical, Inc. Dosage forms using drug-loaded ion exchange resins
EP2233134A1 (en) * 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
WO2012083947A1 (en) * 2010-12-21 2012-06-28 Fertin Pharma A/S Chewing gum composition comprising cross-linked polyacrylic acid
CN104271137A (zh) * 2012-03-26 2015-01-07 阿特法克特里公司 包含封装在水不溶性袋中的粉末的尼古丁口服递送产品,其中所述粉末包括尼古丁和口香糖组合物
US20170172995A1 (en) * 2015-09-08 2017-06-22 Venkateswara Rao Repaka Pharmaceutical compositions of Nicotine and process for preparation thereof
CN109952092A (zh) * 2016-11-18 2019-06-28 费尔廷制药公司 包含独立的黏合剂和赤藓糖醇的片剂
CN109963553A (zh) * 2016-11-18 2019-07-02 费尔廷制药公司 经口递送载剂
WO2018113916A1 (en) * 2016-12-20 2018-06-28 Fertin Pharma A/S A mucoadhesive oromucosal formulation comprising a nicotine complex

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CALUM R PARK ET AL: "Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy", 《INTERNATIONAL JOURNAL OF PHARMACEUTICS》, vol. 237, 31 December 2002 (2002-12-31), pages 215 - 226, XP002279251, DOI: 10.1016/S0378-5173(02)00041-8 *
国家食品药品监督管理局药品审评中心编: "《药品技术评价文集》", 中国医药科技出版社, pages: 226 *

Also Published As

Publication number Publication date
CA3153792A1 (en) 2021-04-15
EP4041191A1 (en) 2022-08-17
US20210106516A1 (en) 2021-04-15
JP2022552491A (ja) 2022-12-16
WO2021069044A1 (en) 2021-04-15
JP7763166B2 (ja) 2025-10-31

Similar Documents

Publication Publication Date Title
JP7763166B2 (ja) 水溶性粘膜付着性ポリマーを有するイオン交換組成物
CN111432840B (zh) 固体经口烟碱制剂
EP3720418B1 (en) Nicotine tablet
US12478579B2 (en) Compressed nicotine lozenge
CA3085066C (en) Formulations providing high nicotine concentrations
CN110621307A (zh) 含有烟碱的口香糖组合物
JPH0948726A (ja) 口腔内速崩壊性製剤およびその製法
AU2003255822A1 (en) Fast dissolving and taste masked oral dosage form comprising sildenafil
EP4447714B1 (en) Nicotine tablet
CN101965180B (zh) 含有异麦芽酮糖醇的混合物
WO2004089343A1 (en) Water soluble tablets
RU2812603C1 (ru) Ионообменная композиция с водорастворимыми мукоадгезивными полимерами
Nagpal et al. Patent innovations in fast dissolving/disintegrating dosage forms
US20240091367A1 (en) Orally disintegrating palatable formulations of drotaverine and method of preparation thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination